- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 33/242 - OrSes composés
Détention brevets de la classe A61K 33/242
Brevets de cette classe: 307
Historique des publications depuis 10 ans
|
2
|
9
|
20
|
44
|
50
|
53
|
43
|
30
|
21
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Shenzhen Profound View Pharmaceutical Technology Co., Ltd. | 19 |
13 |
| Nanobiotix | 112 |
8 |
| The General Hospital Corporation | 4798 |
6 |
| The Regents of the University of California | 20378 |
5 |
| Northwestern University | 3483 |
5 |
| Galera Labs, LLC | 54 |
5 |
| University of Notre Dame du Lac | 588 |
5 |
| Shenzhen Profound-View Pharma Tech Co., Ltd | 13 |
5 |
| Arizona Board of Regents on behalf of Arizona State University | 2788 |
4 |
| Case Western Reserve University | 1859 |
4 |
| Medsenic | 9 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6587 |
3 |
| Board of Regents, The University of Texas System | 6010 |
3 |
| Clene Nanomedicine, Inc. | 34 |
3 |
| Universidad de Chile | 172 |
3 |
| Universiteit Antwerpen | 401 |
3 |
| Universiteit Gent | 1364 |
3 |
| University of Kentucky Research Foundation | 714 |
3 |
| Varian Medical Systems, Inc. | 887 |
3 |
| Seoul National University R&db Foundation | 3891 |
3 |
| Autres propriétaires | 216 |